What we do!
Healthcare Products Regulatory Updates Around the World
Health Canada and TGA Regulatory Cooperation Initiative (RCI) project yielded labelling standard for oral adult expectorant containing guaifenesin as a single ingredient.
Labelling standard for oral adult expectorant
FDA released Guidance document on Global Unique Device Identification Database (GUDID) intended primarily to provide information about submitting data to the database for device Labelers, entities responsible for submitting data to the GUDID.
Guidance document on Global Unique Device Identification Database (GUDID)
2 recent FDA Class II Special Controls Guideline for Industry and Food and Drug Administration Staff released on May 30th 2014:
Nucleic Acid-Based In Vitro Diagnostic Devices for the Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens
Dengue Virus Serological Reagents
Your One-Stop Solution to Healthcare Products Regulatory Compliance!
| Updates |
Copyright © Reg-Affairs & QualiPractixis Inc. 2014. All right reserved.